- Why, as stated
- Closing sites or unitsRestructuring or new strategy · reported
- How
- Sites closing
Talent Risk · Employers · Pharma & healthcare
Novartis
- 322
- Jobs in announced cuts · 12 months
- 0.4%
- Of its staff · 12 months
- 1st Jul 2026
- Latest on record
Novartis is showing signs of job cuts.
Stepping down: cuts in the last 180 days, nothing new in 90. Latest, on 1st July: Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2,…
This record counts only cuts announced publicly or filed as a formal notice; the everyday redundancies at any large employer are rarely announced and are not here.
How to read this page
- The label (Cutting, Signs or Quiet) comes from one published rule applied to the sources listed: the company, formal notices and named outlets. The rule
- The figures count each announcement once. Where a figure is left out, the record says why (one report only, offered not cut, same round).
- Summary says what is happening and what would change the label; Full record lists every report, linked.
What’s happening, and where
No announced or filed job cuts in the last 90 days. The label rests on earlier signs, under Full record.
Which jobs Factory and production
Why, as stated Closing sites or units · Restructuring or new strategy · Cutting costs
Next This becomes Cutting if the company, a formal notice or two major outlets confirm cuts.
The last 12 months
No cuts found this quarter. We found cuts in 2 of the three quarters before.
This label is our opinion, reached by applying one published rule to the sources listed. Novartis can correct the record at any time.
At a glance
| Label | Signs since the week to 3rd Oct |
|---|---|
| Jobs in announced cuts, 12 months | 322 · 0.4% of about 76,000 staff |
| Latest on the record | 1st July 2026 · Cuts announced · 322 jobs |
| Jobs named in cuts | Factory and production |
| Where the jobs are | New Jersey · Stein · US, Switzerland |
| Why, as stated | Closing sites or units · Restructuring or new strategy · Cutting costs · Moving work abroad |
| Jobs we count | 322 of the 1,092 jobs reported, each round once; not counted: 220 in 1 figure: figure given by one report only. How we count |
| Normal for them? | No cuts found this quarter. We found cuts in 2 of the three quarters before. |
| Sources, 12 months | 1 formal notice and 8 reports from 5 outlets, each linked below |
| Headquarters · sector | Switzerland · Pharma & healthcare · NOVN |
| Which company | Novartis AG, the Swiss pharmaceuticals company. Not Sandoz, spun off in 2023. |
Identifiers Wikidata Q507154 · LEI 5493007HIVTX6SY6XD66 · ISIN CH0012005267 · NVS on New York Stock Exchange · NOVN on Swiss Stock Exchange · About these
Filings under 42 other names count for Novartis
A formal notice counts here when it is filed by one of Novartis’s own legal entities, named exactly as below. Names two employers both claim are left out. How we match
Our list
Novartis Pharmaceuticals Corporation · Novartis Pharmaceuticals · Novartis Services · Novartis Gene Therapies
GLEIF register · source
Novartis Kapital AG · EVONILE PHARMA LIMITED · NOVARTIS INDIA LIMITED · NOVARTIS CAPITAL CORPORATION · Novartis Pharma GmbH · Alcon Ophthalmika GmbH · EBEWE Pharma Ges.m.b.H. Nfg.KG · Sandoz GmbH · NOVARTIS BIOVENTURES AG · Novartis International AG · SANDOZ INTERNATIONAL AG · NOVARTIS HEALTHCARE PRIVATE LIMITED · NOVARTIS INVESTMENT, LTD. · NOVARTIS SERVICES, INC. · NOVARTIS FINANCE SA · NOVARTIS PHARMA AG · SANDOZ PHARMA AG · NOVARTIS HOLDING AG · SANDOZ HOLDING AG · Novartis Investments S.à r.l.
Wikidata · source
Sandoz · Alcon · Chiron Corporation · Novartis (Singapore) · Novartis (France) · Novartis (Japan) · Novartis (United Kingdom) · Novartis Healthcare (India) · Novartis (Italy) · Novartis (Canada) · Novartis (Slovenia) · Novartis (Netherlands) · Novartis (Austria) · Novartis (China) · Novartis (Germany) · Novartis (Mexico) · Novartis · Novartis Baltics, SIA
What happened
Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide
Nothing from Novartis, a formal notice or a named outlet about its workforce in the last 90 days.
Earlier on the record (3 events, up to a year)
- 1st JulNovartis to cut 322 jobs322jobs cut
Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2, 2026.
All 2 reports
- 1st Jul
WARN notice (NJ) Official
Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2, 2026.
- 7th Jul
Fierce Pharma Trade press
Novartis announced layoffs of 322 employees at its U.S. headquarters in East Hanover, New Jersey, effective by October 2, 2026, according to a WARN Act filing.
- 1st Jul
- 4th MayNovartis to cut 220 jobs220jobs, not yet confirmed
Novartis announced closure of its Wehr facility in southern Baden, Germany, resulting in 220 job losses. The company is simultaneously investing in a new site in Saxony-Anhalt.
All 3 reports
- 4th May
Fierce Pharma Trade press
Novartis announced 60 additional job cuts at its U.S. headquarters in New Jersey, following 114 cuts announced in March as part of multiyear workforce reductions.
- 4th May
Fierce Pharma Trade press
Novartis announced additional cuts of 60 roles at its U.S. headquarters in East Hanover, New Jersey, following earlier cuts of 114 roles announced in March, as part of multiyear workforce reductions.
- 5th May
Handelsblatt Major outlet
Novartis announced closure of its Wehr facility in southern Baden, Germany, resulting in 220 job losses. The company is simultaneously investing in a new site in Saxony-Anhalt.
- 4th May
- 25th Nov 2025Novartis to cut 550 jobs550jobs cut
Novartis announced 550 job cuts at its largest Swiss manufacturing site in Stein by end of 2027, ceasing tablet and capsule production and sterile packaging there. Work to shift to lower-cost European facilities in Italy and Slovenia.
All 4 reports
- 25th Nov
NZZ Major outlet
Novartis announced 550 job cuts at its largest Swiss manufacturing site in Stein by end of 2027, ceasing tablet and capsule production and sterile packaging there. Work to shift to lower-cost European facilities in Italy and Slovenia.
- 25th Nov
Handelsblatt Major outlet
Novartis announced job cuts at Swiss locations while investing more than $100 million in those sites, prioritizing certain production.
- 25th Nov
Tages-Anzeiger Major outlet
Novartis announced 550 job cuts in Aargau, Switzerland, described as independent from US expansion plans.
- 26th Nov
pharma.economictimes.indiatimes.com Trade press
Novartis announced 550 job cuts in Switzerland as it transforms operations to focus on cell therapies and invests in modernizing production facilities.
- 25th Nov
Before this year: the formal record
Official documents only (US WARN notices and SEC filings) filed for Novartis since 2021. They are shown as filed, one row per document: a round notified at several sites appears once per site. They never change the label, which reads the last 90 days.
| Year | Documents | Jobs they state |
|---|---|---|
| 2025 | 2 | 35 |
| 2024 | 1 | 29 |
| 2023 | 1 | 103 |
| 2022 | 3 | 500 |
| 2021 | 2 | 586 |
Every document (9)
- 27th Mar 2025 WARN notice (CA) Official WARN notice filed for 1 employee in California, effective June 2025. Below the WARN Act threshold of 50 employees and does not constitute a reportable workforce event.
- 12th Mar 2025 WARN notice (CA) Official Novartis Pharmaceuticals Corporation filed a WARN notice for 34 employees in California, effective 2025-06-27.
- 5th Jul 2024 WARN notice (CA) Official Novartis Pharmaceuticals Corporation filed a WARN notice on 2024-07-05 for 29 employees affected by layoffs effective 2024-09-06 at a California location.
- 1st Aug 2023 WARN notice (NJ) Official Novartis Pharmaceuticals filed a WARN notice on 1 August 2023 for 103 employees at its Hanover, NJ facility, effective 24 November 2023.
- 1st Nov 2022 WARN notice (NJ) Official Novartis Services Inc filed a WARN notice for 4 employees at East Hanover, NJ, effective 28 January 2023.
- 1st Nov 2022 WARN notice (NJ) Official Novartis Pharmaceuticals filed a WARN notice for 221 employee layoffs at its East Hanover, NJ facility, effective 2023-01-28.
- 24th Oct 2022 WARN notice (IL) Official Novartis Gene Therapies filed WARN notice of 275 employee layoffs at Libertyville, Illinois facility.
- 1st Jun 2021 WARN notice (NJ) Official Novartis Pharmaceuticals Corporation filed a WARN notice for 186 employees at its East Hanover, NJ facility, effective 2021-09-10.
- 24th Mar 2021 WARN notice (CO) Official Novartis Gene Therapies filed a WARN notice for closure of its Boulder, Colorado facility, affecting 400 employees effective July 9, 2021.
Why, and how
- Why, as stated
- Restructuring or new strategyCutting costsMoving work abroad
- When
- By December 2027
- Where
- Stein
“ist die Schweiz dafür nicht mehr wettbewerbsfähig. Man schaue sich nach alternativen Standorten in Europa um, wo die Lohnkosten und andere Aufwände geringer seien.”
In English: Switzerland is no longer competitive for this. The company is looking for alternative locations in Europe where labor costs and other expenses are lower.
Only what the sources say. If no report gives a reason, we don’t suggest one.
In context
How the label has changed · 26 weeks
| 3rd Oct | Cutting → Signs · Reported, not yet confirmed: trade press only |
|---|---|
| 4th Jul | Signs → Cutting · Confirmed by the company or a formal notice (such as a US WARN notice) |
Against its workforce
Share of its sector’s cuts
12%
of the 2,749 job cuts announced in 12 months by the employers we rate in pharma & healthcare.
Peers in pharma & healthcare
- GSK1.8%
- AstraZeneca0.7%
- Novartis0.4%
- Novo Nordisk0.4%
- Johnson & Johnson0.2%
Job cuts in 12 months as a share of each employer’s workforce.
Right of reply
Novartis can reply or correct this record at any time.
This label is our opinion, reached by applying one published rule to the sources listed.